CONMED Corporation (CNMD)
$51.49+0.82%Close
BUYRECOVERY · day 33
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $1.5B
- Avg volume
- 565.0K
- Beta
- 0.90
- Div yield
- 0.39%
- P/E (TTM)
- 27.80
- Short % float
- 7.49%
- Days to cover
- 3.5
- SI change
- -4.1%
- 1W
- +4.55%
- 1M
- +20.64%
- 3M
- +38.30%
- YTD
- +27.07%
- vs SPY 1W
- +5.74%
- vs SPY 1M
- +17.32%
- vs SPY 3M
- +35.91%
- vs SPY YTD
- +15.32%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- CONBUYConcentra Group Holdings Parent, Inc.BULLQ 41$34.99-0.03%
- MMSIBUYMerit Medical Systems, Inc.BULLQ 13$90.28-0.55%
- FTHBUYRECOVERYQ -5$34.71+8.47%
- HCABUYHCA Healthcare, Inc.RECOVERYQ 24$430.39+0.28%
- ALCBUYAlcon Inc.RECOVERYQ 11$73.70+0.10%
- RDYBUYDr. Reddy's Laboratories LimitedRECOVERYQ 14$12.22+0.33%
- HSTMBUYHealthStream, Inc.BULLQ 12$28.78-0.31%
- ATNMBUYActinium Pharmaceuticals, Inc.RECOVERYQ -1$1.05-4.55%
- TECHBUYBio-Techne CorporationBULLQ 18$72.39+0.10%
- IDXXSELLIDEXX Laboratories, Inc.RECOVERYQ 30$559.51+0.46%
- SHCBUYSotera Health CompanyBULLQ 10$19.17-2.04%
- VRTXBUYVertex Pharmaceuticals IncorporatedBULLQ 23$547.59-0.08%
Industry peers
FMP comparable companies · ranked by market cap
- NEOGBUYNeogen Corporation$2.6BBULLQ 16$11.87-2.93%
- UFPTBUYUFP Technologies, Inc.$2.5BBULLQ 23$321.31-1.21%
- ESTASELLEstablishment Labs Holdings Inc.$2.3BCRISISQ 17$76.62-0.84%
- NVCRBUYNovocure Ltd$2.0BRECOVERYQ 12$17.53-1.99%
- NTLABUYIntellia Therapeutics, Inc.$1.7BRECOVERYQ 3$12.09-2.18%
- KMTSBUYKestra Medical Technologies, Ltd.$1.6BBULLQ 23$27.82-0.30%
- AZTABUYAzenta, Inc.$1.5BRECOVERYQ 9$33.58-12.09%
- INMDSELLInMode Ltd.$863MBULLQ 16$15.02+0.27%
- AHCOSELLAdaptHealth Corp.$790MCRISISQ -1$5.81+0.00%
- SSIISELLSS Innovations International, Inc.$752MRECOVERYQ 17$3.76-2.51%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 32
- VALUE
- 35
- GROWTH
- 56
- GARP
- 11
- TYPE
- Value / Recovery
Composite of Value · Growth · GARP
ROIC3.3%
REV YoY-
ROE5.5%
EPS YoY-
ROA2.5%
GROSS55
OP11
NET4
[VALUATION]
P/E TTM27.80
P/E FWD-
SECTOR PE22.66
INDUSTRY PE24.61
P/B1.49
P/FCF-
EV/EBITDA13.00
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E80.11
ALTMAN Z-
CURR RATIO1.48
ND/EBITDA-
BETA0.90
